Maja Schuang Lü

Department of Radiation Biology and Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark

Disclosure: Nothing to disclose

Presentation(s):

• PATH-28 - Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients

  Friday, November 22
  7:30 PM – 9:30 PM